Over the past four decades, rare disease drug development has evolved from a scientific aspiration into a central pillar of biopharmaceutical innovation. Regulatory reforms, scientific breakthroughs, ...
Bitcoin broke through a key support level, XRP's decline intensified, and market risk appetite continued to cool.
Q4 2025 Earnings Call February 5, 2026 8:00 AM ESTCompany ParticipantsSimon Falk - Head of Equity Investor RelationsLars ...
Liverpool Eye Roma Defender Zeki Celik as Right Back Plans EvolveLiverpool’s recruitment model has long been rooted in ...
Follow X February 5, 2026 Affiliates of Kaiser Permanente have agreed to pay $556 million to resolve federal allegations that ...
FormFactor, Inc. (NASDAQ:FORM) Q4 2025 Earnings Call Transcript February 4, 2026 FormFactor, Inc. beats earnings expectations ...
Cognizant Technology Solutions Corporation (NASDAQ:CTSH) Q4 2025 Earnings Call Transcript February 4, 2026 Cognizant ...
SINGAPORE—“The Hercules refuses to die,” a senior Republic of Singapore Air Force (RSAF) commander once remarked. Since the ...
Should the United States buy more destroyers, or would the money be better spent developing bases, munitions, or software?
At the union's annual press conference on January 26 and in further statements IG Metall chair Christiane Benner has called ...
Q4 2025 Earnings Call February 4, 2026 4:25 PM ESTCompany ParticipantsStan Finkelstein - Head of Investor RelationsMike Slessor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results